System C Healthcare plc
("System C" or the "Company")
Director Shareholding
The Company was informed today that Mrs. Jane McLaren (the wife of Christopher McLaren, Non-executive Director) acquired 19,600 ordinary shares of 1p each in the Company on 5 February 2010, at a price of 51 pence per share.
Accordingly, Mr. McLaren has a beneficial interest in 2,135,987 ordinary shares, representing 1.85 per cent of the issued ordinary share capital of the Company.
Contact:
System C Healthcare plc
Dr Ian Denley, Chief Executive
Tel: 01622 691 616
Charles Stanley Securities
Nominated Adviser
Russell Cook / Jen Boorer
Tel: 020 7149 6000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.